SG Americas Securities’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-94,796
Closed -$84K 3659
2022
Q4
$84K Buy
94,796
+41,074
+76% +$54.5K ﹤0.01% 2767
2022
Q3
$84K Sell
53,722
-363,094
-87% -$824K ﹤0.01% 2898
2022
Q2
$838K Buy
+416,816
New +$721K 0.01% 1452
2022
Q1
Sell
-46,245
Closed -$215K 3610
2021
Q4
$215K Sell
46,245
-63,632
-58% -$395K ﹤0.01% 2638
2021
Q3
$838K Buy
109,877
+97,200
+767% +$824K ﹤0.01% 2055
2021
Q2
$123K Sell
12,677
-30,951
-71% -$246K ﹤0.01% 2555
2021
Q1
$361K Buy
43,628
+20,433
+88% +$216K ﹤0.01% 2241
2020
Q4
$158K Sell
23,195
-107,275
-82% -$862K ﹤0.01% 2771
2020
Q3
$1.46M Buy
130,470
+91,428
+234% +$837K 0.01% 973
2020
Q2
$245K Sell
39,042
-6,405
-14% -$24.5K ﹤0.01% 2691
2020
Q1
$84K Buy
+45,447
New +$131K ﹤0.01% 3066
2019
Q4
Sell
-13,149
Closed -$28K 3494
2019
Q3
$28K Buy
+13,149
New +$30.6K ﹤0.01% 2880
2018
Q4
Sell
-12,774
Closed -$56K 3421
2018
Q3
$56K Sell
12,774
-5,314
-29% -$29.5K ﹤0.01% 2954
2018
Q2
$130K Buy
+18,088
New +$123K ﹤0.01% 2906

Other funds holding SRNE

SG Americas Securities's SRNE Position: Q1 2023 in Review

SG Americas Securities sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 94,796 shares — an estimated $84K sold.

SG Americas Securities first reported a position in SRNE in Q2 2018 and held it in 14 quarters. The position peaked at $1.46M in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • SG Americas Securities reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • SG Americas Securities sold 94,796 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $84K.
  • SG Americas Securities first reported a position in Sorrento Therapeutics, Inc. in Q2 2018 and held it in 14 quarters.
  • SG Americas Securities's Sorrento Therapeutics, Inc. position peaked at $1.46M in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on SG Americas Securities's 13F filing for Q1 2023, filed 28 Apr 2023.